Skip to main content
Top
Published in: Metabolic Brain Disease 1/2009

01-03-2009 | Original Paper

Hepatitis C virus infection and the brain

Authors: Karin Weissenborn, Anita B. Tryc, Meike Heeren, Hans Worthmann, Henning Pflugrad, Georg Berding, Martin Bokemeyer, Hans L. Tillmann, Annemarie Goldbecker

Published in: Metabolic Brain Disease | Issue 1/2009

Login to get access

Abstract

There is growing evidence that hepatitis C virus (HCV)-infection may affect the brain. About half of the HCV-infected patients complain of chronic fatigue irrespective of their stage of liver disease or virus replication rate. Even after successful antiviral therapy fatigue persists in about one third of the patients. Many patients, in addition, report of deficits in attention, concentration and memory, some also of depression. Psychometric testing revealed deficits in attention and verbal learning ability as characteristic for HCV-afflicted patients with normal liver function. Magnetic resonance spectroscopic studies showed alterations of the cerebral choline, N-acetyl-aspartate, and creatine content in the basal ganglia, white matter and frontal cortex, respectively. Recently, pathologic cerebral serotonin and dopamine transporter binding and regional alterations of the cerebral glucose utilisation compatible with alterations of the dopaminergic attentional system were observed. Several studies detected HCV in brain samples or cerebro-spinal fluid. Interestingly, viral sequences in the brain often differed from those in the liver, but were closely related to those found in lymphoid tissue. Therefore, the Trojan horse hypothesis emerged: HCV-infected mononuclear blood cells enter the brain, enabling the virus to reside within the brain (probably in microglia) and to infect brain cells, especially astrocytes.
Literature
go back to reference Adair D, Wilkinson J, Scheck A, Radkowski M, Rakela J, Laskus T (2004) Differential display and microarray analysis show differentially expressed genes in central nervous system in HCV infected patients and laser capture microscopy points to brain microglia as cells harboring HCV. Hepatology 40:433A Adair D, Wilkinson J, Scheck A, Radkowski M, Rakela J, Laskus T (2004) Differential display and microarray analysis show differentially expressed genes in central nervous system in HCV infected patients and laser capture microscopy points to brain microglia as cells harboring HCV. Hepatology 40:433A
go back to reference Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J (2003) Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 39:231–238PubMedCrossRef Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J (2003) Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 39:231–238PubMedCrossRef
go back to reference Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F (2006) Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepatitis 13:402–408CrossRef Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F (2006) Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepatitis 13:402–408CrossRef
go back to reference Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infectious Diseases 197:597–607CrossRef Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD (2008) Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infectious Diseases 197:597–607CrossRef
go back to reference Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L, the HALT C trial group (2005) Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 43: 614–623PubMedCrossRef Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L, the HALT C trial group (2005) Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 43: 614–623PubMedCrossRef
go back to reference Fontana RJ, Bieliauskas LA, Lindsay KL, Back-Madruga C, Wright EC, Snow KK, Lok ASF, Kronfol Z, Padmanabhan L, the HALT-C Trial Group (2007) Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 45:1154–1163PubMedCrossRef Fontana RJ, Bieliauskas LA, Lindsay KL, Back-Madruga C, Wright EC, Snow KK, Lok ASF, Kronfol Z, Padmanabhan L, the HALT-C Trial Group (2007) Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 45:1154–1163PubMedCrossRef
go back to reference Forton DM (2006). Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunological condition? GUT 55 (11): 1535–1537CrossRef Forton DM (2006). Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunological condition? GUT 55 (11): 1535–1537CrossRef
go back to reference Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38-39PubMedCrossRef Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38-39PubMedCrossRef
go back to reference Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433–439PubMedCrossRef Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35:433–439PubMedCrossRef
go back to reference Forton DM, Karayianni P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virology 78(10):5170–5183PubMedCrossRef Forton DM, Karayianni P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virology 78(10):5170–5183PubMedCrossRef
go back to reference Forton DM, Taylor-Robinson S, Thoma HC (2006) Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 18:333–338PubMedCrossRef Forton DM, Taylor-Robinson S, Thoma HC (2006) Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 18:333–338PubMedCrossRef
go back to reference Foster GR, Goldin RD, Thomas HC (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209–212PubMedCrossRef Foster GR, Goldin RD, Thomas HC (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209–212PubMedCrossRef
go back to reference Hassoun Z, Willems B, Deslauriers J, Nguyen BN, Huet PM (2002) Assessment of fatigue in patients with chronic hepatitis C using the fatigue impact scale. Dig Dis Sci 47(12):2674–2681PubMedCrossRef Hassoun Z, Willems B, Deslauriers J, Nguyen BN, Huet PM (2002) Assessment of fatigue in patients with chronic hepatitis C using the fatigue impact scale. Dig Dis Sci 47(12):2674–2681PubMedCrossRef
go back to reference Hüppe D, Zehnter E, Mauss S, Böker K, Lutz T, Racky S, Schmidt W, Ullrich J, Sbrijer I, Heyne R, Schober A, John C, Hey KH, Bokemeyer B, Kallinowski B, Miller B, Pape S, Gutmann M, Alshuth U, Niederau C (2008) Epidemiolgie der chronischen Hepatitis C in Deutschland—Eine Analyse von 10326 Hepatitis C-Virus-Infizierten aus Schwerpunktpraxen und—ambulanzen. Z Gastrenterol 46:34–44CrossRef Hüppe D, Zehnter E, Mauss S, Böker K, Lutz T, Racky S, Schmidt W, Ullrich J, Sbrijer I, Heyne R, Schober A, John C, Hey KH, Bokemeyer B, Kallinowski B, Miller B, Pape S, Gutmann M, Alshuth U, Niederau C (2008) Epidemiolgie der chronischen Hepatitis C in Deutschland—Eine Analyse von 10326 Hepatitis C-Virus-Infizierten aus Schwerpunktpraxen und—ambulanzen. Z Gastrenterol 46:34–44CrossRef
go back to reference Jones EA (1999) Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. Lancet 354:397PubMedCrossRef Jones EA (1999) Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. Lancet 354:397PubMedCrossRef
go back to reference Jüngling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K. (2000) Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152(4): 383–389CrossRef Jüngling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K. (2000) Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 152(4): 383–389CrossRef
go back to reference Kallman J, O’Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM (2007) Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 52:2531–2539PubMedCrossRef Kallman J, O’Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM (2007) Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 52:2531–2539PubMedCrossRef
go back to reference Karaivazoglou K, Assimakopoulos K, Thomopoulos K, Theocharis G, Messinis L, Sakellaropoulos G, Labropoulou-Karatza C (2007) Neuropsychological function in Greek patients with chronic hepatitis C. Liver International 27(6):798–805PubMedCrossRef Karaivazoglou K, Assimakopoulos K, Thomopoulos K, Theocharis G, Messinis L, Sakellaropoulos G, Labropoulou-Karatza C (2007) Neuropsychological function in Greek patients with chronic hepatitis C. Liver International 27(6):798–805PubMedCrossRef
go back to reference Kenny-Walsh E (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340(16):1228–1233 Kenny-Walsh E (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340(16):1228–1233
go back to reference Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J (2005) Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19(suppl 3):S140–S144PubMedCrossRef Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J (2005) Emerging evidence of hepatitis C virus neuroinvasion. AIDS 19(suppl 3):S140–S144PubMedCrossRef
go back to reference Laskus T, Radkowski M, Bednarska A, Wikinson J, Adair D, Nowicki M, Nikolopoulou GB, Vargas H, Rakela J (2002) Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 76:10064–10068PubMedCrossRef Laskus T, Radkowski M, Bednarska A, Wikinson J, Adair D, Nowicki M, Nikolopoulou GB, Vargas H, Rakela J (2002) Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 76:10064–10068PubMedCrossRef
go back to reference McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ (2005) Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41(4): 801–808CrossRef McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ (2005) Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41(4): 801–808CrossRef
go back to reference Niederau C, Bemba G, Kautz A (2006) Sozioökonomische Charakteristika, Lebensqualität und Wissensstand bei Patienten mit Hepatitis C-Virusinfektion in Deutschland. Z Gastroenterol 44:305–317PubMedCrossRef Niederau C, Bemba G, Kautz A (2006) Sozioökonomische Charakteristika, Lebensqualität und Wissensstand bei Patienten mit Hepatitis C-Virusinfektion in Deutschland. Z Gastroenterol 44:305–317PubMedCrossRef
go back to reference Niederau C, Fischer C, Kautz A (2007) Sozioökonomische Charakteristika, Lebensqualität und Wissensstand bei Patienten mit Hepatitis B-Virusinfektion in Deutschland. Sozioökonomische Aspekte der Hepatitis B. Z Gastroenterol 45:355–368PubMedCrossRef Niederau C, Fischer C, Kautz A (2007) Sozioökonomische Charakteristika, Lebensqualität und Wissensstand bei Patienten mit Hepatitis B-Virusinfektion in Deutschland. Sozioökonomische Aspekte der Hepatitis B. Z Gastroenterol 45:355–368PubMedCrossRef
go back to reference Niederau C, Bemba G, Kautz A (2008) Entwicklung von sozioökonomischen Charakteristika, Lebensqualität und Wissensstand bei patienten mit Hepatitis C während des Projektes Kompetenznetz Hepatitis. Z Gastroenterologie 46:22–33CrossRef Niederau C, Bemba G, Kautz A (2008) Entwicklung von sozioökonomischen Charakteristika, Lebensqualität und Wissensstand bei patienten mit Hepatitis C während des Projektes Kompetenznetz Hepatitis. Z Gastroenterologie 46:22–33CrossRef
go back to reference Piche T, Vanbiervliet G, Cherikh F, Antoun Z, Huet PM, Gelsi E, Damarquay J-F, Caroli-Bosc F-X, Benzaken S, Rigault M-C, Renou C, Rampal P, Tran A (2005) Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 54:1169–1173PubMedCrossRef Piche T, Vanbiervliet G, Cherikh F, Antoun Z, Huet PM, Gelsi E, Damarquay J-F, Caroli-Bosc F-X, Benzaken S, Rigault M-C, Renou C, Rampal P, Tran A (2005) Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 54:1169–1173PubMedCrossRef
go back to reference Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, Ghillani P, Charlotte F, Piette JC, Moussalli J (2002) Fatigue in patients with chronic hepatitis C. Journal of Viral Hepatitis 2002; 9: 295–303CrossRef Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, Ghillani P, Charlotte F, Piette JC, Moussalli J (2002) Fatigue in patients with chronic hepatitis C. Journal of Viral Hepatitis 2002; 9: 295–303CrossRef
go back to reference Provencher SW (1995) Automated estimation of metabolite concentrations from localized proton MRS. New prospects in psychiatry. The bio-clinical interface:405–413. Provencher SW (1995) Automated estimation of metabolite concentrations from localized proton MRS. New prospects in psychiatry. The bio-clinical interface:405–413.
go back to reference Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T (2002) Search for hepatitis c virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76(2):600–608PubMedCrossRef Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T (2002) Search for hepatitis c virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 76(2):600–608PubMedCrossRef
go back to reference Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N (1999) The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30:1299–1301PubMedCrossRef Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N (1999) The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 30:1299–1301PubMedCrossRef
go back to reference Soogoor M, Lynn HS, Donfield SM, Gomperts E, Bell TS, Daar ES, for the Hemophilia Growth and Development Study (2006) Hepatitis C virus infection and neurocognitive function. Neurology 67:1482–1485PubMedCrossRef Soogoor M, Lynn HS, Donfield SM, Gomperts E, Bell TS, Daar ES, for the Hemophilia Growth and Development Study (2006) Hepatitis C virus infection and neurocognitive function. Neurology 67:1482–1485PubMedCrossRef
go back to reference Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34(5):768–773PubMedCrossRef Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34(5):768–773PubMedCrossRef
go back to reference Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schüler A, Ennen JC, Ahl B, Manns MP, Böker KW (2004) Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41(5):845–851PubMedCrossRef Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schüler A, Ennen JC, Ahl B, Manns MP, Böker KW (2004) Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41(5):845–851PubMedCrossRef
go back to reference Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. GUT 55(11):1624–1630PubMedCrossRef Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. GUT 55(11):1624–1630PubMedCrossRef
go back to reference Wiese M, Berr F, Lafrenz M, Porst H, Oesen U (2000) Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology 32:91–96PubMedCrossRef Wiese M, Berr F, Lafrenz M, Porst H, Oesen U (2000) Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study. Hepatology 32:91–96PubMedCrossRef
go back to reference Wiese M, Grüngreiff K, Güthoff W, Lafrenz M, Oesen U, Porst H, for the East German Hepatitis C Study Group (2005) Outcome in a hepatitis C (genotype 1b). Single source outbreak in Germany—a 25 year multicenter study. J Hepatology 43(4):590–598CrossRef Wiese M, Grüngreiff K, Güthoff W, Lafrenz M, Oesen U, Porst H, for the East German Hepatitis C Study Group (2005) Outcome in a hepatitis C (genotype 1b). Single source outbreak in Germany—a 25 year multicenter study. J Hepatology 43(4):590–598CrossRef
Metadata
Title
Hepatitis C virus infection and the brain
Authors
Karin Weissenborn
Anita B. Tryc
Meike Heeren
Hans Worthmann
Henning Pflugrad
Georg Berding
Martin Bokemeyer
Hans L. Tillmann
Annemarie Goldbecker
Publication date
01-03-2009
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 1/2009
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-008-9130-5

Other articles of this Issue 1/2009

Metabolic Brain Disease 1/2009 Go to the issue